Protective effects of p38 MAPK inhibitor SB202190 against hippocampal apoptosis and spatial learning and memory deficits in a rat model of vascular dementia

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Yang, Shen ^a,b   Zhou, Guangan ^b   Liu, Hong ^c   Zhang, Bo ^b   Li, Juan ^b   Cui, Ruiting ^b   Du, Yifeng ^a  

^a SHANDONG UNIVERSITY   (China)

^b TAIAN CENTRAL HOSPITAL   (China)

^c Liaocheng Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 3; DIMETHYL SULFOXIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BCL 2; 4-(4-FLUOROPHENYL)-2-(4-HYDROXYPHENYL)-5-(4-PYRIDYL)IMIDAZOLE; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; LATENT PERIOD; MALE; MECHANICAL PROBE; MORRIS WATER MAZE TEST; MULTIINFARCT DEMENTIA; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; RAT MODEL; SPATIAL LEARNING; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LEARNING DISORDER; MEMORY DISORDER; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY;

ANIMALS; APOPTOSIS; CASPASE 3; DEMENTIA, VASCULAR; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; IMIDAZOLES; LEARNING DISORDERS; MEMORY DISORDERS; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRIDINES; RATS;

EID: 84896089343     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/215798     Document Type: Article

References (39)

1. Battistin L., Cagnin A., Vascular cognitive disorder. A biological and clinical overview. Neurochemical Research 2010 35 12 1933 1938 2-s2.0-78651301462 10.1007/s11064-010-0346-5
2. Catindig J. A., Venketasubramanian N., Ikram M. K., Chen C., Epidemiology of dementia in Asia: insights on prevalence, trends and novel risk factors. Journal of the Neurological Sciences 2012 321 1-2 11 16
3. Venketasubramanian N., Sahadevan S., Kua E. H., Chen C. P. L., Ng T.-P., Interethnic differences in dementia epidemiology: global and Asia-Pacific perspectives. Dementia and Geriatric Cognitive Disorders 2011 30 6 492 498 2-s2.0-79251508690 10.1159/000321675
4. Brundel M., De Bresser J., Van Dillen J. J., Kappelle L. J., Biessels G. J., Cerebral microinfarcts: a systematic review of neuropathological studies. Journal of Cerebral Blood Flow and Metabolism 2012 32 3 425 436 2-s2.0-84857792576 10.1038/jcbfm.2011.200
5. Rincon F., Wright C. B., Vascular cognitive impairment. Current Opinion in Neurology 2013 26 1 29 36
6. Buzsaki G., Moser E. I., Memory, navigation and theta rhythm in the hippocampal-entorhinal system. Nature Neuroscience 2013 16 2 130 138
7. Philbert M. A., Billingsley M. L., Reuhl K. R., Mechanisms of injury in the central nervous system. Toxicologic Pathology 2000 28 1 43 53 2-s2.0-0033980203 (Pubitemid 30078205)
8. Fang M., Li J., Tiu S. C., Zhang L., Wang M., Yew D. T., N-methyl-D-aspartate receptor and apoptosis in Alzheimer's disease and multiinfarct dementia. Journal of Neuroscience Research 2005 81 2 269 274 2-s2.0-23844448681 10.1002/jnr.20558 (Pubitemid 41153341)
9. Niswander J. M., Dokas L. A., Hyperosmotic stress-induced caspase-3 activation is mediated by p38 MAPK in the hippocampus. Brain Research 2007 1186 1 1 11 2-s2.0-37649015217 10.1016/j.brainres.2007.10.008
10. Wu X. D., Zhang Z. Y., Sun S., Hypoxic preconditioning protects microvascular endothelial cells against hypoxia/reoxygenation injury by attenuating endoplasmic reticulum stress. Apoptosis 2013 18 1 85 98
11. Irving E. A., Barone F. C., Reith A. D., Hadingham S. J., Parsons A. A., Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat. Molecular Brain Research 2000 77 1 65 75 2-s2.0-0034646936 10.1016/S0169-328X(00)00043-7 (Pubitemid 30256193)
12. Legos J. J., Erhardt J. A., White R. F., Lenhard S. C., Chandra S., Parsons A. A., Tuma R. F., Barone F. C., SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia. Brain Research 2001 892 1 70 77 2-s2.0-0035895803 10.1016/S0006-8993(00)03228-5 (Pubitemid 32126568)
13. Wang X. L., Lv P. Y., Guo Z. C., The study of expression of p38 MAPK mRNA in neuron of hippocampus in mice with vascular dementia. Journal of Apoplexy and Nervous Diseases 2008 2 014
14. Sasaki T., Kitagawa K., Yagita Y., Sugiura S., Omura-Matsuoka E., Tanaka S., Matsushita K., Okano H., Tsujitnoto Y., Hori M., Bcl2 enhances survival of newborn neurons in the normal and ischemic hippocampus. Journal of Neuroscience Research 2006 84 6 1187 1196 2-s2.0-33750429935 10.1002/jnr.21036 (Pubitemid 44654442)
15. Ashabi G., Alamdary S. Z., Ramin M., Khodagholi F., Reduction of hippocampal apoptosis by intracerebroventricular administration of extracellular signal-regulated protein kinase and/or p38 inhibitors in amyloid beta rat model of Alzheimer's disease: involvement of nuclear-related factor-2 and nuclear factor- B. Basic & Clinical Pharmacology & Toxicology 2013 112 3 145 155
16. Sunkaria A., Verma D., Gill K., Quercetin attenuates aluminum-induced apoptosis in rat hippocampus, by preventing cytochrome c translocation, Bcl-2 decrease, bax elevation, caspase-3 and p53 activation. Free Radical Biology and Medicine 2012 53 S44 S45
17. Chen M., Sun H.-Y., Li S.-J., Das M., Kong J.-M., Gao T.-M., Nitric oxide as an upstream signal of p38 mediates hypoxia/reoxygenation-induced neuronal death. NeuroSignals 2009 17 2 162 168 2-s2.0-61349092908 10.1159/000205525
18. D'Hooge R., De Deyn P. P., Applications of the Morris water maze in the study of learning and memory. Brain Research Reviews 2001 36 1 60 90 2-s2.0-0034888287 10.1016/S0165-0173(01)00067-4 (Pubitemid 32763130)
19. Kyrylkova K., Kyryachenko S., Leid M., Kioussi C., Detection of apoptosis by TUNEL assay. Methods Molecular Biology 2012 887 41 47
20. Barbierato M., Argentini C., Skaper S. D., Indirect immunofluorescence staining of cultured neural cells. Methods in Molecular Biology 2012 846 235 246 2-s2.0-84859854113 10.1007/978-1-61779-536-7-21
21. Sekhon L. H. S., Morgan M. K., Spence I., Weber N. C., Chronic cerebral hypoperfusion: pathological and behavioral consequences. Neurosurgery 1997 40 3 548 556 2-s2.0-0031019527 10.1097/00006123-199703000-00025 (Pubitemid 27108128)
22. Duarte S., Shen X. D., Fondevila C., Busuttil R. W., Coito A. J., Fibronectin-alpha4beta1 interactions in hepatic cold ischemia and reperfusion injury: regulation of MMP-9 and MT1-MMP via the p38 MAPK pathway. American Journal of Transplantation 2012 12 10 2689 2699
23. Woodruff T. M., Thundyil J., Tang S.-C., Sobey C. G., Taylor S. M., Arumugam T. V., Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Molecular Neurodegeneration 2011 6 1, article 11 2-s2.0-78951485462 10.1186/1750-1326-6-11
24. Xu S. Y., Pan S. Y., The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy. Medical Science Monitor Basic Research 2013 19 37 45
25. Shibata M., Ohtani R., Ihara M., Tomimoto H., White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 2004 35 11 2598 2603 2-s2.0-7644244605 10.1161/01.STR.0000143725.19053.60 (Pubitemid 39458424)
26. Krafft P. R., Bailey E. L., Lekic T., Etiology of stroke and choice of models. International Journal of Stroke 2012 7 5 398 406
27. Casals J. B., Pieri N. C. G., Feitosa M. L. T., Ercolin A. C. M., Roballo K. C. S., Barreto R. S. N., Bressan F. F., Martins D. S., Miglino M. A., Ambrósio C. E., The use of animal models for stroke research: a review. Comparative Medicine 2011 61 4 305 313 2-s2.0-84857477089
28. Oberheim N. A., Takano T., Han X., He W., Lin J. H. C., Wang F., Xu Q., Wyatt J. D., Pilcher W., Ojemann J. G., Ransom B. R., Goldman S. A., Nedergaard M., Uniquely hominid features of adult human astrocytes. Journal of Neuroscience 2009 29 10 3276 3287 2-s2.0-63849175251 10.1523/JNEUROSCI.4707-08.2009
29. Barreto G., White R. E., Ouyang Y., Xu L., Giffard R. G., Astrocytes: targets for neuroprotection in stroke. Central Nervous System Agents in Medicinal Chemistry 2011 11 2 164 173 2-s2.0-79959318466
30. Walberer M., Stolz E., Müller C., Friedrich C., Rottger C., Blaes F., Kaps M., Fisher M., Bachmann G., Gerriets T., Experimental stroke: ischaemic lesion volume and oedema formation differ among rat strains (a comparison between Wistar and Sprague-Dawley rats using MRI). Laboratory Animals 2006 40 1 1 8 2-s2.0-33644754151 10.1258/002367706775404426 (Pubitemid 43341078)
31. Barone F. C., Irving E. A., Ray A. M., Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Medicinal Research Reviews 2001 21 2 129 145 (Pubitemid 32185244)
32. Takeda K., Ichiijo H., Neuronal p38 MAPK signalling: an emerging regulator of cell fate and function in the nervous system. Genes to Cells 2002 7 11 1099 1111 2-s2.0-0036840971 10.1046/j.1365-2443.2002.00591.x (Pubitemid 35264519)
33. Yasuda S., Sugiura H., Tanaka H., Takigami S., Yamagata K., p38 MAP kinase inhibitors as potential therapeutic drugs for neural diseases. Central Nervous System Agents in Medicinal Chemistry 2011 11 1 45 59 2-s2.0-79953008825
34. Fernandez F., Soon I., Li Z., Wip1 phosphatase positively modulates dendritic spine morphology and memory processes through the p38MAPK signaling pathway. Cell Migration Assays 2012 6 4 333 343
35. Zhao Y. N., Li J. M., An C. W., Zhang X. Y., Li S. X., Cheng C. X., Effect of Buyanghuanwu recipe on p38MAPK/neuronal apoptosis signal pathway and learning-memory function after forebrain ischemia-reperfusion injury in gerbils. Pharmacology and Clinics of Chinese Materia Medica 2010 2 003
36. Hua F., Cornejo M. G., Cardone M. H., Stokes C. L., Lauffenburger D. A., Effects of Bcl-2 levels on Fas signaling-induced caspase-3 activation: molecular genetic tests of computational model predictions. The Journal of Immunology 2005 175 2 985 995 (Pubitemid 41094983)
37. Hata R., Gillardon F., Michaelidis T. M., Hossmann K.-A., Targeted disruption of the bcl-2 gene in mice exacerbates focal ischemic brain injury. Metabolic Brain Disease 1999 14 2 117 124 2-s2.0-0032857768 10.1023/A: 1020709814456 (Pubitemid 29418694)
38. Yang Y., Zhang S.-M., Fan S.-Y., Zhang M., Jiang H., Xu K., Chang L.-H., Effects of activation of caspase-3 in cerebral ischemic reperfusion injury. Zhonghua yi xue za zhi 2004 84 12 1035 1037 2-s2.0-16544393507
39. Liu B., Mao W. J., Li A. C., Effect of shenxiong huayu capsule on expression of p38MAPK in CA1 area of hippocampus in vascular dementia rats. Chinese Journal of Experimental Traditional Medical Formulae 2010 8 161 165